Skip to content
TrialScanner

NCT04035733

rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects

Phase 2CompletedAKTXLead

Registry record

Lead sponsor
AKARI Therapeutics
Conditions
Bullous Pemphigoid (BP)
Primary completion
Mar 12, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04035733 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04035733: rVA576 in Adult Mild to... | TrialScanner